Drug name - Sunosi
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8877806 | JAZZ | Treatment of sleep-wake disorders |
Jun, 2026
(3 years from now) | |
| US10351517 | JAZZ | Treatment of sleep-wake disorders |
Jun, 2026
(3 years from now) | |
| US9604917 | JAZZ | Treatment of sleep-wake disorders |
Jun, 2026
(3 years from now) | |
| US8440715 | JAZZ | Treatment of sleep-wake disorders |
Aug, 2027
(4 years from now) | |
| US10195151 | JAZZ | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
Sep, 2037
(14 years from now) | |
| US10512609 | JAZZ | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
Sep, 2037
(14 years from now) | |
| US10912754 | JAZZ | Methods and compositions for treating excessive sleepiness |
Jun, 2038
(15 years from now) | |
| US10959976 | JAZZ | Methods and compositions for treating excessive sleepiness |
Jun, 2038
(15 years from now) | |
| US10940133 | JAZZ | Methods of providing solriamfetol therapy to subjects with impaired renal function |
Mar, 2040
(17 years from now) | |
Drugs and Companies using SOLRIAMFETOL HYDROCHLORIDE ingredient
Treatment: To improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (osa); Treatment of excessive daytime sleepiness associated with obstructive sleep apnea (osa) in an adult through a dosing regimen that includes oral administration of 75 mg once daily for at least 3 days followed by 150 mg once daily; To improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (osa) with a dosing regimen that includes a dose of 75 mg once daily for at least 3 days followed by 150 mg once daily; Treatment of excessive daytime sleepiness associated with obstructive sleep apnea (osa) in a patient with moderate renal impairment
Dosage: TABLET;ORAL
| Strength | Dosage | Availability |
|---|---|---|
| EQ 75MG BASE | TABLET;ORAL | Prescription |
| EQ 150MG BASE | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.